Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing PCI: Adequate Time in Therapeutic INR Range

Image

Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing PCI: Adequate Time in Therapeutic INR Range

Atherosclerosis: Open Access (Omics Publishing S.L) has announced almost 50 % discount on article processing charge to commemorate its 10th Anniversary.

Atherosclerosis: Open Access is an open access, peer-reviewed journal that focuses and welcomes submissions on all aspects of Coronary Heart disease, Stroke, Peripheral Arterial Disease, Chronic Kidney Disease, arteriosclerosis, Coronary Atherosclerosis, intracranial atherosclerosis etc.  

It gives us great pleasure to announce the call for paper on the occasion of 10th Anniversary of the Journal at special and hefty discount of up to 50 % on one-time article processing charge. Prospective academicians and scientists are encouraged to utilize this opportunity to get their articles reviewed, processed and published at relatively faster pace and at lower charges. In addition to this, the authors who publish with us during the year-long celebrations will also be eligible for academic awards recommended by the editorial panel.

The Archive page contains wide variety of articles such as Research / Review / Case reports / short communication / Mini review / Prospective / Letter to Editors Etc. We would like introduce a Mini Review which has been spread to the widest audience of experts; and thus increased in readership, citations and altimetry score.

Title: “Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing PCI: Adequate Time in Therapeutic INR Range

Abstract: Dual anti-platelet therapy (DAPT) is a standard procedure for patients undergoing percutaneous coronary intervention (PCI) using stents, whereas oral anticoagulation (OAC) is necessary, when CHADS2 -VASc scores are ≥ 2, to reduce stroke and embolic events in patients with atrial fibrillation (AF). Coronary artery disease (CAD) and AF often coexists in same patient, approximately 5-10% of patients who underwent PCI have AF. Some studies have reported that DAPT with OAC (triple antithrombotic therapy [TT]) reduces major cardiovascular events and mortality compared with DAPT only in patients who underwent PCI with AF. On the other hand, others have found that TT increases the bleeding and cardiovascular events. Therefore, the optical combination antithrombotic therapy for the patients with AF undergoing PCI is uncertain.

To have a glance at the full length manuscript, you can visit us at our archive page and Currently, Journal’s Archive is holding not only normal issues but also focusing on special issues. The purpose of special issues is to publish the most exciting research with respect to the subjects of Atherosclerosis / Cardiovascular Diseases and to provide a rapid turn-around time regarding reviewing and publishing, and to publicize the articles freely for research, teaching and reference purposes. Submit manuscript of your research articles or special issue articles online through manuscript submission or forwarded to the Editorial Office at atherosclerosis@oajournal.org

Media Contact:

Steven Edwards

Editorial Assistant

Atherosclerosis: Open Access

Email: atherosclerosis@oajournal.org